Letter to the Editor on “Does the Use of Tranexamic Acid in Patients Who Have Preoperative Coagulopathy Undergoing Total Joint Arthroplasty Normalize Their Risk of Complications? A Matched Equivalence Analysis”
The Journal of Arthroplasty · 2024
DOI: 10.1016/j.arth.2024.02.070 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Arthroplasty, 2024. Verfasst von Xiangji Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Second Hospital of Dalian Medical University, Dalian, Liaoning Province, PR China. Hauptthemen laut MEDLINE: Tranexamic Acid, Antifibrinolytic Agents, Blood Coagulation Disorders. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Dalian Medical University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The Second Hospital of Dalian Medical University, Dalian, Liaoning Province, PR China.
Förderung
- Dalian Medical University
Zitieren
APA
Liu, X., & Wu, H. (2024). Letter to the Editor on “Does the Use of Tranexamic Acid in Patients Who Have Preoperative Coagulopathy Undergoing Total Joint Arthroplasty Normalize Their Risk of Complications? A Matched Equivalence Analysis”. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.02.070
Vancouver
Liu X, Wu H. Letter to the Editor on “Does the Use of Tranexamic Acid in Patients Who Have Preoperative Coagulopathy Undergoing Total Joint Arthroplasty Normalize Their Risk of Complications? A Matched Equivalence Analysis”. The Journal of Arthroplasty. 2024. doi:10.1016/j.arth.2024.02.070
BibTeX
@article{Liu2024,
author = {Liu, Xiangji and Wu, Hao},
title = {Letter to the Editor on “Does the Use of Tranexamic Acid in Patients Who Have Preoperative Coagulopathy Undergoing Total Joint Arthroplasty Normalize Their Risk of Complications? A Matched Equivalence Analysis”},
journal = {The Journal of Arthroplasty},
year = {2024},
doi = {10.1016/j.arth.2024.02.070}
}
EUVIMED